|Christopher R. Kinsinger, Ph.D., is a program manager for NCI’s Clinical Proteomic Tumor Analysis Consortium (CPTAC). He focuses on the expansion and coordination of open data access and programmatic goals involving mass spectrometry, informatics, and biospecimens. In this role he works with NCI staff and investigators to optimize proteomics technology, establish policies for sharing data and biospecimens, and generally improve the quality and reliability of proteomic measurements. He completed postdoctoral training at NIST, where he researched fragmentation pathways of peptide ions in mass spectrometry. He holds a Ph.D. degree in chemistry (2004) from the University of Minnesota. |
The Skyline software project for clinical proteomics: lessons learned
In a world where thousands of software projects start up and fail each year, what factors distinguish highly adopted software like Skyline from the rest? Aside from having good code, what is the bigger picture that allowed Skyline software development to take off? A history of Skyline will be presented, within the context of the National Cancer Institute’s Clinical Proteomic Tumor Analysis Consortium (CPTAC), where Skyline grew from an idea to critical enabling technology. Both sociological and investment considerations will be explored.